Skip to content
OpenCapital
Get started

Intellia Therapeutics NTLA Short-Term Investments

Short-Term Investments at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$1.12B-9.4%
ALN
Alnylam PharmaceuticalsALNY
$1.3B-19.1%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$2.02B+24.6%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$923.36M+33.4%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$116.94M-37.8%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$585.84M+12.6%

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.17B+106%

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's short-term investments?
Intellia Therapeutics (NTLA) reported short-term investments of $241.29M in Q1 2026.
How has Intellia Therapeutics's short-term investments changed year-over-year?
Intellia Therapeutics's short-term investments decreased by 36.0% year-over-year, from $376.87M to $241.29M.
What is the long-term trend for Intellia Therapeutics's short-term investments?
Over 5 years (2020 to 2025), Intellia Therapeutics's short-term investments has grown at a -7.6% compound annual growth rate (CAGR), from $437.35M to $294.42M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.